cro.directory
← Compare landing

Fortrea vs PrimeVigilance

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/fortrea/primevigilance

CategoryFortreaPrimeVigilance
Listed sitecrocro
SummaryFortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.Pharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Central Laboratory Services
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Clinical Imaging Core Lab
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Regulatory Affairs
  • Clinical Operations
  • Clinical Trial Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Cell Therapy
  • Gene Therapy
  • Vaccine
Indications
  • Cardiovascular
  • Metabolic
  • Dermatology
  • Infectious Disease
  • Immunology
  • Nephrology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Respiratory
  • Women's Health
  • Gastroenterology
  • Infectious Disease
Locations
  • Global operations, United States
  • Headquarters, Durham, NC, United States
  • Dallas, Dallas, TX, United States
  • Daytona Beach, Daytona Beach, FL, United States
  • Madison, Madison, WI, United States
  • Sydney, Sydney, NSW, Australia
  • Beijing, Beijing, China
  • Chengdu, Chengdu, Sichuan, China
  • Dalian, Dalian, Liaoning, China
  • Guangzhou, Guangzhou, China
  • Hangzhou, Hangzhou, Zhejiang, China
  • Hong Kong, Hong Kong, China
  • Nanjing, Nanjing, Jiangsu, China
  • Shanghai, Shanghai, China
  • Seoul, Seoul, South Korea
  • Taipei, Taipei, Taiwan
  • Tokyo, Tokyo, Japan
  • Raanana, Raanana, Israel
  • Istanbul, Istanbul, Turkey
  • Bogotá, Bogotá, Colombia
  • Buenos Aires, Buenos Aires, Argentina
  • Lima, Lima, Peru
  • Mexico City, Mexico City, CDMX, Mexico
  • Santiago, Santiago, Chile
  • São Paulo, São Paulo, SP, Brazil
  • Centurion, Centurion, Gauteng, South Africa
  • Clinical Research Unit, Dallas, TX, United States
  • Clinical Research Unit, Daytona Beach, FL, United States
  • Clinical Research Unit, Madison, WI, United States
  • Office, São Paulo, SP, Brazil
  • Office, Mexico City, CDMX, Mexico
  • Office, Buenos Aires, Argentina
  • Office, Santiago, Chile
  • Office, Lima, Peru
  • Office, Bogotá, Colombia
  • Office, Centurion, Gauteng, South Africa
  • Office, Sydney, NSW, Australia
  • Office, Beijing, China
  • Office, Shanghai, China
  • Office, Guangzhou, China
  • Office, Chengdu, Sichuan, China
  • Office, Dalian, Liaoning, China
  • Office, Hangzhou, Zhejiang, China
  • Office, Nanjing, Jiangsu, China
  • Office, Hong Kong, China
  • Office, Tokyo, Japan
  • Office, Seoul, South Korea
  • Office, Taipei, Taiwan
  • Office, Raanana, Israel
  • Office, Istanbul, Turkey
  • Office, Herzliya, Israel
  • Herzliya, Raanana, Israel
  • Herzliya, Herzliya, Israel
  • Office, Hong Kong, Hong Kong
  • Headquarters, Guildford, Surrey, United Kingdom
  • North Carolina, Raleigh, North Carolina, United States
  • United States, United States, United States
  • Canada, Canada, Canada
  • Argentina, Argentina, Argentina
  • Colombia, Colombia, Colombia
  • Australia, Australia, Australia
  • Ireland, Ireland, Ireland
  • The Netherlands, The Netherlands, The Netherlands
  • Germany, Germany, Germany
  • France, France, France
  • Switzerland, Switzerland, Switzerland
  • Spain, Spain, Spain
  • Portugal, Portugal, Portugal
  • Poland, Poland, Poland
  • Czech Republic, Czech Republic, Czech Republic
  • Croatia, Croatia, Croatia
  • Serbia, Serbia, Serbia
  • Bosnia and Herzegovina, Bosnia and Herzegovina, Bosnia and Herzegovina
  • Bulgaria, Bulgaria, Bulgaria
  • Romania, Romania, Romania
  • Russia, Russia, Russia
  • Ukraine, Ukraine, Ukraine
  • India, India, India
  • Japan, Japan, Japan
Certifications
  • cGMP · Identifier: In-clinic cGMP Pharmacies
  • FDA · Identifier: cGMP
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.